842 related articles for article (PubMed ID: 28348030)
1. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
[TBL] [Abstract][Full Text] [Related]
2. Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression.
Bowe B; Xie Y; Xian H; Balasubramanian S; Al-Aly Z
Kidney Int; 2016 Apr; 89(4):886-96. PubMed ID: 26924057
[TBL] [Abstract][Full Text] [Related]
3. Monocyte count modifies the association between chronic kidney disease and risk of death
.
Koraishy FM; Bowe B; Xie Y; Xian H; Al-Aly Z
Clin Nephrol; 2018 Sep; 90(3):194-208. PubMed ID: 29974856
[TBL] [Abstract][Full Text] [Related]
4. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
6. Retinopathy and progression of CKD: The CRIC study.
Grunwald JE; Pistilli M; Ying GS; Daniel E; Maguire MG; Xie D; Whittock-Martin R; Parker Ostroff C; Lo JC; Townsend RR; Gadegbeku CA; Lash JP; Fink JC; Rahman M; Feldman HI; Kusek JW;
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1217-24. PubMed ID: 24812423
[TBL] [Abstract][Full Text] [Related]
7. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
8. Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
Sumida K; Kwak L; Grams ME; Yamagata K; Punjabi NM; Kovesdy CP; Coresh J; Matsushita K
Am J Kidney Dis; 2017 Nov; 70(5):675-685. PubMed ID: 28754455
[TBL] [Abstract][Full Text] [Related]
9. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.
Bansal N; Fan D; Hsu CY; Ordonez JD; Marcus GM; Go AS
Circulation; 2013 Feb; 127(5):569-74. PubMed ID: 23275377
[TBL] [Abstract][Full Text] [Related]
10. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
[TBL] [Abstract][Full Text] [Related]
11. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
12. Sex-Related Disparities in CKD Progression.
Ricardo AC; Yang W; Sha D; Appel LJ; Chen J; Krousel-Wood M; Manoharan A; Steigerwalt S; Wright J; Rahman M; Rosas SE; Saunders M; Sharma K; Daviglus ML; Lash JP;
J Am Soc Nephrol; 2019 Jan; 30(1):137-146. PubMed ID: 30510134
[TBL] [Abstract][Full Text] [Related]
13. Particulate Matter Air Pollution and the Risk of Incident CKD and Progression to ESRD.
Bowe B; Xie Y; Li T; Yan Y; Xian H; Al-Aly Z
J Am Soc Nephrol; 2018 Jan; 29(1):218-230. PubMed ID: 28935655
[TBL] [Abstract][Full Text] [Related]
14. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease.
Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC
Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714
[TBL] [Abstract][Full Text] [Related]
15. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.
Heung M; Steffick DE; Zivin K; Gillespie BW; Banerjee T; Hsu CY; Powe NR; Pavkov ME; Williams DE; Saran R; Shahinian VB;
Am J Kidney Dis; 2016 May; 67(5):742-52. PubMed ID: 26690912
[TBL] [Abstract][Full Text] [Related]
16. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
[TBL] [Abstract][Full Text] [Related]
17. Progressive Decline in Estimated GFR in Patients With Sickle Cell Disease: An Observational Cohort Study.
Derebail VK; Ciccone EJ; Zhou Q; Kilgore RR; Cai J; Ataga KI
Am J Kidney Dis; 2019 Jul; 74(1):47-55. PubMed ID: 30797615
[TBL] [Abstract][Full Text] [Related]
18. Plasma Homocysteine Is a Predictive Factor for Accelerated Renal Function Decline and Chronic Kidney Disease in a Community-Dwelling Population.
Xiao W; Ye P; Wang F; Cao R; Bai Y; Wang X
Kidney Blood Press Res; 2021; 46(5):541-549. PubMed ID: 34365457
[TBL] [Abstract][Full Text] [Related]
19. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
Fung E; Chang TI; Chertow GM; Thomas IC; Asch SM; Kurella Tamura M
Am J Kidney Dis; 2017 Nov; 70(5):705-714. PubMed ID: 28811048
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Chonchol M; Gitomer B; Isakova T; Cai X; Salusky I; Pereira R; Abebe K; Torres V; Steinman TI; Grantham JJ; Chapman AB; Schrier RW; Wolf M
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1461-1469. PubMed ID: 28705885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
